Delivery Order SPE2DR25D1205-SPE2DR26F0XP7
Award Date 12/3/25
Potential Completion Date 12/4/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,960.24 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a medication commonly prescribed for type 2 diabetes management. This is a firm fixed-price, non-set-aside contract awarded on November 18, 2025, with completion scheduled for November 19, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,735.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a common oral medication used to treat type 2 diabetes. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of April 23, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,130.48 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Glimepiride 4 mg tablets (100-count units). This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive, non-set-aside procurement. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $11,456.09 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $9,638.98 delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a $1,119.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a diabetes medication. The delivery order, issued on October 31, 2025, requires completion by November 3, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. This award was made without a set-aside designation, indicating it was competitively awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,846.63 for Glimepiride 4 mg tablets (100-count units) on April 30, 2025, with an ultimate completion date of May 1, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,977.70 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,174.34 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...